Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients

Serum BCMA levels predict outcomes in MGUS and smoldering myeloma patients

Abstract Soluble BCMA (sBCMA) levels are elevated in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). However, the association between sBCMA levels and prognosis in MGUS and SMM has not been studied. We retrospectively analyzed sBCMA levels in stored s...

Full description

Bibliographic Details
Main Authors: A. Visram, C. Soof, S. V. Rajkumar, S. K. Kumar, S. Bujarski, T. M. Spektor, R. A. Kyle, J. R. Berenson, A. Dispenzieri
Format: Article
Language:English
Published: Nature Publishing Group 2021-06-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-021-00505-4

Internet

https://doi.org/10.1038/s41408-021-00505-4

Similar Items